3.11
-0.08 (-2.51%)
Previous Close | 3.19 |
Open | 3.15 |
Volume | 125,529 |
Avg. Volume (3M) | 198,486 |
Market Cap | 18,316,406 |
Price / Sales | 0.780 |
Price / Book | 2.45 |
52 Weeks Range | |
Earnings Date | 31 Mar 2025 |
Profit Margin | -86.19% |
Operating Margin (TTM) | -68.52% |
Diluted EPS (TTM) | -4.99 |
Quarterly Revenue Growth (YOY) | 16.90% |
Total Debt/Equity (MRQ) | 21.44% |
Current Ratio (MRQ) | 1.44 |
Operating Cash Flow (TTM) | -12.50 M |
Levered Free Cash Flow (TTM) | -8.98 M |
Return on Assets (TTM) | -60.87% |
Return on Equity (TTM) | -325.98% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Mixed | Mixed |
Medical Devices (Global) | Mixed | Mixed | |
Stock | Vivos Therapeutics, Inc. | Mixed | - |
AIStockmoo Score
Analyst Consensus | NA |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | -2.5 |
Average | -1.50 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Value |
% Held by Insiders | 8.00% |
% Held by Institutions | 13.70% |
No data within this time range.
No data within this time range.
Date | Type | Details |
---|---|---|
28 Mar 2025 | Announcement | Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call |
24 Feb 2025 | Announcement | Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide |
18 Feb 2025 | Announcement | Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET. |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |